• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Biobanking Market Analysis

    ID: MRFR/HC/4511-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Biobanking Market Research Report By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Application (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End-use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations), By Storage Type (Vapor Phase Storage, Liquid Phase ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Biobanking Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Biobanking Market Industry Landscape

    The Biobanking Market is seeing unique growth, filled by the rising interest for excellent organic samples for research and clinical purposes. Biobanks act as vaults for putting away usual examples, assuming a vital part in propelling clinical examination, drug revelation, and customized medicine. Biobanks assume a vital part in drug revelation and improvement. Drug organizations and research foundations depend on biobanked samples for biomarker disclosure, target ID, and preclinical testing. This dynamic adds to the extension of the Biobanking Market. With the rising noticeable quality of genomic research, biobanks are vital for gathering and protecting DNA samples. These storehouses support enormous scope genomic studies, genome-wide association studies (GWAS), and research zeroed in on figuring out the hereditary premise of illnesses. The raising worldwide burden of ongoing illnesses has elevated the significance of biobanking in recognizing biomarkers for early illness identification and checking. Biobanked samples empower analysts to investigate the molecular signatures related with different circumstances, making ready for further developed diagnostics and designated treatments. Productive information management and coordination have become basic in biobanking tasks. The joining of vigorous informatics arrangements empowers consistent classifying, following, and recovery of samples, encouraging a more smoothed out and coordinated way to deal with biobank management. Public mindfulness and local area commitment drives are urgent for the progress of biobanking projects. Building entrusts with benefactors, guaranteeing straightforwardness in activities, and stressing the cultural advantages of biobanking add to expanded giver cooperation and test variety. Guaranteeing variety in example assortments is earning respect as a basic part of biobanking. Addressing assorted populations in biobanks improves the suitability of exploration discoveries across various ethnic meetings, diminishing differences in medical care results. An arising pattern in the Biobanking Market is the attention on undifferentiated cell banking. Biobanks are progressively putting away and safeguarding different kinds of undeveloped microorganisms, giving an important asset to regenerative medicine, cell treatment, and future biomedical applications.

    Market Summary

    The Global Biobanking Market is projected to grow from 75.39 USD Billion in 2024 to 117.55 USD Billion by 2035, reflecting a steady expansion.

    Key Market Trends & Highlights

    Biobanking Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.1% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 8 USD Billion, indicating robust growth potential. in 2024, the market is valued at 75.39 USD Billion, establishing a solid foundation for future expansion. Growing adoption of biobanking technologies due to increasing demand for personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 75.39 (USD Billion)
    2035 Market Size 117.55 (USD Billion)
    CAGR (2025-2035) 4.12%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Becton Dickinson, Biolife Solutions, Charles River Laboratories, BioCision, Thermo Fisher Scientific, STEMCELL Technologies, Reprocell, VWR Corporation, USA Biologics, Procurement Services, Genomatica, Asterand Bioscience, Qiagen, SigmaAldrich, Merck KGaA</p>

    Market Trends

    A number of important variables are propelling the notable expansion of the Biobanking Market. The growing need for targeted therapeutics and customized medicine, which necessitate large biobanks that supply a variety of biological samples, is one of the main factors propelling the market.

    Global biobanking efforts are also being accelerated by developments in genomics and biotechnology, as nations make significant infrastructural investments to improve research capacities. Funding and policy support have increased as a result of governments and organizations realizing the value of biobanks for disease and public health research, which has aided in the growth of international biobank networks.

    The Biobanking Market is experiencing a significant expansion in opportunities. Collaboration between pharmaceutical firms and biobanks has the potential to result in advances in drug development and a deeper comprehension of illnesses. Furthermore, incorporating AI and machine learning into biobank operations can improve sample handling and data processing, generating new insights and efficiency. These new technologies provide biobanks a critical chance to boost their worth and research utility.

    Current patterns show that biobanking is moving toward uniform procedures and laws across geographical boundaries. International research partnerships are facilitated by efforts to standardize sample collection, storage, and dissemination procedures, which enhance biorepositories' quality and credibility. Additionally, ethical issues and informed consent—which guarantees that participants are aware of how their biological samples will be used—are becoming more and more important. Growing public knowledge of biobanks emphasizes the need of openness and participation, which will strengthen the foundation for biobanking projects in the long run. All of these patterns point to a vibrant and changing Biobanking Market.

     

    <p>The Global Biobanking Market is poised for expansion, driven by increasing demand for personalized medicine and advancements in genomic research, which underscore the critical role of biobanks in facilitating innovative healthcare solutions.</p>

    U.S. National Institutes of Health (NIH)

    Biobanking Market Market Drivers

    Market Growth Projections

    The Global Biobanking Market Industry is projected to experience substantial growth, with estimates indicating a market value of 5.14 USD Billion in 2024 and a potential increase to 8 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 4.1% from 2025 to 2035. Factors contributing to this expansion include increasing demand for personalized medicine, advancements in technology, and growing investment in research and development. As the market evolves, it is likely to attract further interest from stakeholders across various sectors, including healthcare, pharmaceuticals, and biotechnology.

    Regulatory Support and Standardization

    Regulatory support and standardization are pivotal in shaping the Global Biobanking Market Industry. Governments are establishing frameworks to ensure ethical practices in biobanking, which enhances public trust and encourages participation. Standardization of sample collection, processing, and storage protocols is essential for maintaining data integrity and reproducibility in research. As regulatory bodies continue to refine guidelines, biobanks are better positioned to meet the demands of researchers and healthcare providers. This regulatory environment is likely to contribute to the market's growth, with projections indicating a rise to 5.14 USD Billion in 2024.

    Rising Awareness of Biobanking Benefits

    Rising awareness of the benefits of biobanking is driving participation and investment in the Global Biobanking Market Industry. Educational initiatives aimed at healthcare professionals and the public are highlighting the critical role biobanks play in advancing medical research and improving patient care. Increased understanding of how biobanks contribute to disease prevention, diagnosis, and treatment is likely to enhance public willingness to donate biological samples. This heightened awareness is expected to support the market's growth, with projections indicating a rise to 5.14 USD Billion in 2024 and further growth towards 8 USD Billion by 2035.

    Technological Advancements in Biobanking

    Technological advancements are transforming the Global Biobanking Market Industry, enabling more efficient sample management and data analysis. Innovations such as automated sample processing, advanced biorepositories, and sophisticated data analytics tools are enhancing the operational capabilities of biobanks. These technologies facilitate the integration of large datasets, allowing for more comprehensive research outcomes. As a result, biobanks can better support personalized medicine initiatives and large-scale epidemiological studies. The market's growth trajectory, with an expected value of 8 USD Billion by 2035, is indicative of the significant impact that technology has on biobanking practices.

    Increasing Demand for Personalized Medicine

    The Global Biobanking Market Industry is witnessing a surge in demand for personalized medicine, which relies heavily on biobanks for genetic and biological samples. This trend is driven by advancements in genomics and biotechnology, enabling tailored treatments for various diseases. For instance, biobanks facilitate the identification of genetic markers associated with specific conditions, thereby enhancing the efficacy of therapies. As the market evolves, the value is projected to reach 5.14 USD Billion in 2024, with expectations of expanding to 8 USD Billion by 2035, reflecting a compound annual growth rate of 4.1% from 2025 to 2035.

    Growing Investment in Research and Development

    Investment in research and development within the Global Biobanking Market Industry is on the rise, as governments and private entities recognize the importance of biobanks in advancing medical research. Funding initiatives are increasingly directed towards biobanking infrastructure, which supports the collection, storage, and analysis of biological samples. This investment not only enhances the capabilities of biobanks but also fosters collaboration between academic institutions and industry stakeholders. The anticipated growth in the market, reaching 8 USD Billion by 2035, underscores the critical role that R&D plays in driving innovation and improving healthcare outcomes.

    Market Segment Insights

    Biobanking Market Sample Type Insights

    <p>The Biobanking Market focused heavily on various sample types, which play a critical role in the research and development of medical and biological sciences. Blood Products led this segment with a valuation of 1.5 USD Billion in 2024, and it is expected to rise to 2.4 USD Billion by 2035, making it a major player due to the extensive use of blood for diagnostics and therapeutic developments.</p>

    <p>Tissues were valued at 1.2 USD Billion in 2024 and are anticipated to grow to 1.9 USD Billion by 2035, reflecting the increasing utilization of tissue samples in regenerative medicine and cancer research. Cells also held a notable position, valued at 1.4 USD Billion in 2024 and projected to reach 2.2 USD Billion in 2035.</p>

    <p>The importance of cells, particularly stem cells, in clinical therapies and drug discovery drove their market significance. Nucleic Acids, essential for genetic research and personalized medicine, registered a valuation of 0.8 USD Billion in 2024 and are expected to expand to 1.3 USD Billion by 2035, showcasing the growing focus on genomics.</p>

    Biobanking Market Application Insights

    <p>The Biobanking Market, specifically within the Application segment, plays a crucial role in advancing healthcare and research initiatives worldwide. This segment encompasses vital areas such as Research and Development, Clinical Trials, Personalized Medicine, and Regenerative Medicine.</p>

    <p>Research and Development is integral as it underpins innovation, providing researchers with critical biological samples for various studies. Clinical Trials are significantly bolstered by biobanks, as they supply essential data that enhances the efficiency and effectiveness of testing new therapies.</p>

    <p>Personalized Medicine is gaining momentum, driven by advancements in genetic research that enable tailored patient treatment strategies based on biobanked samples. Regenerative Medicine focuses on creating therapies to restore damaged tissues and organs, emphasizing the importance of biobanking in developing future healthcare solutions. The Biobanking Market data indicates strong growth opportunities, primarily driven by technological advancements and increased funding for biomedical research, although challenges such as regulatory compliance and ethical concerns persist in this evolving industry.</p>

    Biobanking Market End-use Insights

    <p>The Biobanking Market is witnessing significant growth, driven by a strong demand across various End-use sectors, primarily in Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, and Government Organizations.</p>

    <p>Academic Research Institutions play a pivotal role as they utilize biobanks to conduct advanced genetic research and clinical trials, supporting the evolving landscape of personalized medicine. Biotechnology Companies are also major contributors, leveraging biobanking resources to innovate and develop new therapies, which enhances their competitive edge in the industry.</p>

    <p>Pharmaceutical Companies increasingly depend on biobanks for drug discovery and validation processes, emphasizing their importance in bringing new therapeutics to market efficiently. Government Organizations support biobank initiatives through funding and regulatory frameworks, facilitating the integration of biobanks into public health strategies. Together, these sectors represent the backbone of the Biobanking Market, underscoring the relevance of biobanks in advancing healthcare, ensuring compliance, and supporting research initiatives worldwide. The overall market growth is further propelled by increasing investments in healthcare and technological advancements in biobanking procedures.</p>

    Biobanking Market Storage Type Insights

    <p>Within the market, the Storage Type segment plays a crucial role, encompassing various storage methods essential for the preservation of biological samples. The segment can be defined through methods such as Vapor Phase Storage, Liquid Phase Storage, and Cryopreservation Storage.</p>

    <p>Vapor Phase Storage is increasingly gaining traction due to its capacity to maintain samples at ultra-low temperatures, thus ensuring sample integrity over extended periods. Liquid Phase Storage remains a favored choice for various biobanking applications, as it provides stable conditions that allow for a wide range of biological materials to be preserved effectively.</p>

    <p>Cryopreservation Storage is critical in the biobanking industry, facilitating long-term storage solutions for cells and tissues while ensuring their viability for research and clinical applications. The combination of these storage types is vital as they not only meet regulatory requirements but also cater to the evolving needs of research and healthcare sectors, propelling the Biobanking Market growth while addressing demands for high-quality preservation techniques.</p>

    Get more detailed insights about Biobanking Market Research Report-Forecast to 2035

    Regional Insights

    The Biobanking Market showed substantial regional diversification, with North America leading the way in market value, estimated at 2.3 USD Billion in 2024 and projected to reach 3.5 USD Billion in 2035. This region displayed majority holding, driven by strong Research and Development initiatives and advanced healthcare infrastructure.

    Europe followed with a valuation of 1.4 USD Billion in 2024 and 2.1 USD Billion in 2035, where innovative biobanking practices and stringent regulations support the industry's growth. In South America, the market was valued at 0.3 USD Billion in 2024, with an expected rise to 0.5 USD Billion by 2035, reflecting increasing awareness about biobanking and its applications.

    Asia Pacific, valued at 0.9 USD Billion in 2024 and 1.4 USD Billion in 2035, showed significant potential as growing investment in biotechnology and healthcare fuels market growth. The Middle East and Africa, although smaller at 0.2 USD Billion in 2024 with an increase to 0.5 USD Billion by 2035, emerged slowly due to government initiatives in improving healthcare services and biobanking facilities. The nuances across these regions highlighted varied opportunities, challenges, and trends shaping the Biobanking Market dynamics and overall market growth.

    Biobanking Market Regional Insights

    Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

    Key Players and Competitive Insights

    The Biobanking Market is a rapidly evolving sector with significant competitive dynamics that reflect its importance in healthcare, research, and diagnostics. As biobanks store biological samples essential for developing personalized medicine, drug discovery, and various genetic studies, understanding the competition among key players becomes crucial for stakeholders.

    The market is characterized by numerous organizations implementing strategic initiatives such as collaborations, mergers, and acquisitions to enhance their technological capabilities and expand their geographical footprint. This competitive landscape underscores the importance of innovation and quality in biobanking services and solutions, as companies vie to establish themselves as leaders in this essential industry.

    Becton Dickinson holds a prominent position in the Biobanking Market, primarily due to its advanced product offerings and strong commitment to innovation. The company's strengths lie in its technical expertise and comprehensive range of biobanking solutions, which include specialized collection devices, storage systems, and preservation technologies that cater to the needs of various biobanking operations.

    Through sustained investments in research and development, Becton Dickinson has successfully integrated cutting-edge technologies into its products, enhancing efficiency and quality in sample handling and preservation. The company's extensive global reach further solidifies its market presence, establishing it as a trusted provider of biobanking solutions essential for research and clinical applications.

    Biolife Solutions operates as a significant player in the Biobanking Market, recognized for its innovative cryopreservation services and solutions. With a focus on high-performance biopreservation media and related products, Biolife Solutions delivers essential tools that support the preservation and transportation of biological samples, thereby sustaining their viability over time.

    The company's approach has led to a strong market presence, supported by strategic collaborations and acquisitions to broaden its product portfolio and scale its services across the global landscape. Biolife Solutions has built a reputation for high-quality standards and reliability in the biobanking sector, making it a preferred partner for researchers and institutions engaged in critical biological studies and regenerative medicine. Through its continuous focus on technological advancements and customer satisfaction, Biolife Solutions aims to enhance its competitive edge in the evolving landscape of the Biobanking Market.

    Key Companies in the Biobanking Market market include

    Industry Developments

    In an effort to increase diversity and advance personalized medicine initiatives, the U.S. National Institutes of Health (NIH) extended the All of Us Research Program in June 2025 to include the biospecimens of 500,000 more individuals.

    In order to strengthen domestic sample integrity and supply, Thermo Fisher Scientific stated in May 2025 that it will invest $2 billion to modernize cold-chain and analytical facilities inside its biobanking division in North America.

    With £45 million in financing, a partnership led by Genomics England and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) launched Project Genome of Europe in March 2025 with the goal of accelerating pan-EU research collaborations and harmonizing cross-national biobanking standards.

    In order to strengthen Asia-Pacific research capacity, AIG Hospital in southern India launched its first regional biobank in November 2024 with the goal of collecting and storing over 100,000 tissue and blood samples over the next ten years.

    Initial results showing effective federated learning deployment across biobanks for multiple sclerosis research were released in October 2024 by the Clinnova effort, a cooperation between France, Germany, Switzerland, and Luxembourg, emphasizing privacy protection and interoperability.

    The European biobanking network, BBMRI-ERIC, announced in April 2024 that the number of participating institutions had increased by 12%, indicating improved standardization and sample-sharing capabilities. Additionally, around 25% of biobanks in North America explored blockchain initiatives in early 2024 to safeguard data access and sample tracking processes.

    Future Outlook

    Biobanking Market Future Outlook

    <p>The Global Biobanking Market is projected to grow at a 4.12% CAGR from 2025 to 2035, driven by advancements in personalized medicine, increased research funding, and rising demand for biobanked samples.</p>

    New opportunities lie in:

    • <p>Develop innovative biobanking technologies to enhance sample preservation and retrieval efficiency. Expand partnerships with pharmaceutical companies for collaborative research using biobanked samples. Invest in data analytics solutions to leverage biobanking data for personalized healthcare applications.</p>

    <p>By 2035, the Global Biobanking Market is expected to be robust, reflecting substantial growth and innovation.</p>

    Market Segmentation

    Biobanking Market End-use Outlook

    • Academic Research Institutions
    • Biotechnology Companies
    • Pharmaceutical Companies
    • Government Organizations

    Biobanking Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Biobanking Market Application Outlook

    • Research and Development
    • Clinical Trials
    • Personalized Medicine
    • Regenerative Medicine

    Biobanking Market Sample Type Outlook

    • Blood Products
    • Tissues
    • Cells
    • Nucleic Acids
    • Microbiome Samples

    Biobanking Market Storage Type Outlook

    • Vapor Phase Storage
    • Liquid Phase Storage
    • Cryopreservation Storage

    Report Scope

    Report Attribute/MetricDetails
    Market Size 202475.39(USD Billion)
    Market Size 2035117.55 (USD Billion)
    Compound Annual Growth Rate (CAGR)4.12% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledBecton Dickinson, Biolife Solutions, Charles River Laboratories, BioCision, Thermo Fisher Scientific, STEMCELL Technologies, Reprocell, VWR Corporation, USA Biologics, Procurement Services, Genomatica, Asterand Bioscience, Qiagen, SigmaAldrich, Merck KGaA
    Segments CoveredSample Type, Application, End-use, Storage Type, Regional
    Key Market OpportunitiesPersonalized medicine advancements, Increased funding for research, Growing demand for biobanked samples, Technological innovations in storage, Expansion in emerging markets
    Key Market DynamicsIncreasing demand for personalized medicine, Growth in biopharmaceutical research, Advancements in genomic technologies, Rising government investments, Enhanced awareness of precision medicine
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 202578.50 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Biobanking market?

    The Biobanking market is the expected increase in total market value of 117.55 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Biobanking market?

    Biobanking market size was valued at approximately 75.39 billion USD in 2024. This figure will reach 117.55 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Biobanking market?

    Biobanking market is expected to grow at a CAGR of 4.12% between 2025 and 2035.

    How much will the Biobanking market be worth by 2035?

    Biobanking market is expected to be worth of 117.55 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Biobanking market perform over the next 10 years?

    Over the next 10 years the Biobanking market is expected to shift from usd billion 75.39 to 117.55 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What was the market size of the Biobanking Market in 2024?

    The Biobanking Market was valued at 5.14 billion USD in 2024.

    What will the market size be for the European region in 2035?

    The market size for Europe is projected to reach 2.1 billion USD by 2035.

    What was the market size for blood products in 2024?

    The market size for blood products in 2024 was 1.5 billion USD.

    Who are the key players in the Biobanking Market?

    Key players include Becton Dickinson, Biolife Solutions, and Thermo Fisher Scientific among others.

    What is the anticipated market size for microbiome samples by 2035?

    The anticipated market size for microbiome samples in 2035 is expected to be 0.2 billion USD.

    1. Table of Contents
    2. EXECUTIVE SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH METHODOLOGY
    16. Overview
    17. Data Mining
    18. Secondary Research
    19. Primary Research
    20. Primary Interviews and Information Gathering Process
    21. Breakdown of Primary Respondents
    22. Forecasting Model
    23. Market Size Estimation
    24. Bottom-Up Approach
    25. Top-Down Approach
    26. Data Triangulation
    27. Validation
    28. MARKET DYNAMICS
    29. Overview
    30. Drivers
    31. Restraints
    32. Opportunities
    33. MARKET FACTOR ANALYSIS
    34. Value chain Analysis
    35. Porter's Five Forces Analysis
    36. Bargaining Power of Suppliers
    37. Bargaining Power of Buyers
    38. Threat of New Entrants
    39. Threat of Substitutes
    40. Intensity of Rivalry
    41. COVID-19 Impact Analysis
    42. Market Impact Analysis
    43. Regional Impact
    44. Opportunity and Threat Analysis
    45. Biobanking Market, BY Sample Type (USD Billion)
    46. Blood Products
    47. Tissues
    48. Cells
    49. Nucleic Acids
    50. Microbiome Samples
    51. Biobanking Market, BY Application (USD Billion)
    52. Research and Development
    53. Clinical Trials
    54. Personalized Medicine
    55. Regenerative Medicine
    56. Biobanking Market, BY End Use (USD Billion)
    57. Academic Research Institutions
    58. Biotechnology Companies
    59. Pharmaceutical Companies
    60. Government Organizations
    61. Biobanking Market, BY Storage Type (USD Billion)
    62. Vapor Phase Storage
    63. Liquid Phase Storage
    64. Cryopreservation Storage
    65. Biobanking Market, BY Regional (USD Billion)
    66. North America
    67. US
    68. Canada
    69. Europe
    70. Germany
    71. UK
    72. France
    73. Russia
    74. Italy
    75. Spain
    76. Rest of Europe
    77. APAC
    78. China
    79. India
    80. Japan
    81. South Korea
    82. Malaysia
    83. Thailand
    84. Indonesia
    85. Rest of APAC
    86. South America
    87. Brazil
    88. Mexico
    89. Argentina
    90. Rest of South America
    91. MEA
    92. GCC Countries
    93. South Africa
    94. Rest of MEA
    95. Competitive Landscape
    96. Overview
    97. Competitive Analysis
    98. Market share Analysis
    99. Major Growth Strategy in the Biobanking Market
    100. Competitive Benchmarking
    101. Leading Players in Terms of Number of Developments in the Biobanking Market
    102. Key developments and growth strategies
    103. New Product Launch/Service Deployment
    104. Merger & Acquisitions
    105. Joint Ventures
    106. Major Players Financial Matrix
    107. Sales and Operating Income
    108. Major Players R&D Expenditure. 2023
    109. Company Profiles
    110. Novogene
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. BD
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Thermo Fisher Scientific
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. Global Biobank
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Oxford Biomedica
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. VWR
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. Biobase
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. Sampled
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Celerion
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. Qiagen
    165. Financial Overview
    166. Products Offered
    167. Key Developments
    168. SWOT Analysis
    169. Key Strategies
    170. MilliporeSigma
    171. Financial Overview
    172. Products Offered
    173. Key Developments
    174. SWOT Analysis
    175. Key Strategies
    176. Libra Bioscience
    177. Financial Overview
    178. Products Offered
    179. Key Developments
    180. SWOT Analysis
    181. Key Strategies
    182. STEMCELL Technologies
    183. Financial Overview
    184. Products Offered
    185. Key Developments
    186. SWOT Analysis
    187. Key Strategies
    188. Beckman Coulter
    189. Financial Overview
    190. Products Offered
    191. Key Developments
    192. SWOT Analysis
    193. Key Strategies
    194. Tecan
    195. Financial Overview
    196. Products Offered
    197. Key Developments
    198. SWOT Analysis
    199. Key Strategies
    200. Appendix
    201. References
    202. Related Reports

    Biobanking Market Segmentation

    Biobanking Market By Sample Type (USD Billion, 2019-2035)

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    Biobanking Market By Application (USD Billion, 2019-2035)

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    Biobanking Market By End Use (USD Billion, 2019-2035)

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    Biobanking Market By Storage Type (USD Billion, 2019-2035)

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    Biobanking Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Biobanking Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    North America Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    North America Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    North America Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    North America Biobanking Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    US Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    US Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    US Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    CANADA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    CANADA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    CANADA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    Europe Outlook (USD Billion, 2019-2035)

    Europe Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    Europe Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    Europe Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    Europe Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    Europe Biobanking Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    GERMANY Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    GERMANY Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    GERMANY Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    UK Outlook (USD Billion, 2019-2035)

    UK Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    UK Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    UK Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    UK Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    FRANCE Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    FRANCE Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    FRANCE Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    RUSSIA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    RUSSIA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    RUSSIA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    ITALY Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    ITALY Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    ITALY Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    SPAIN Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    SPAIN Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    SPAIN Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    REST OF EUROPE Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    REST OF EUROPE Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    REST OF EUROPE Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    APAC Outlook (USD Billion, 2019-2035)

    APAC Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    APAC Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    APAC Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    APAC Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    APAC Biobanking Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    CHINA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    CHINA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    CHINA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    INDIA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    INDIA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    INDIA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    JAPAN Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    JAPAN Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    JAPAN Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    SOUTH KOREA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    SOUTH KOREA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    SOUTH KOREA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    MALAYSIA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    MALAYSIA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    MALAYSIA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    THAILAND Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    THAILAND Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    THAILAND Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    INDONESIA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    INDONESIA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    INDONESIA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    REST OF APAC Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    REST OF APAC Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    REST OF APAC Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    South America Outlook (USD Billion, 2019-2035)

    South America Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    South America Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    South America Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    South America Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    South America Biobanking Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    BRAZIL Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    BRAZIL Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    BRAZIL Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    MEXICO Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    MEXICO Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    MEXICO Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    ARGENTINA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    ARGENTINA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    ARGENTINA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    REST OF SOUTH AMERICA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    REST OF SOUTH AMERICA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    REST OF SOUTH AMERICA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    MEA Outlook (USD Billion, 2019-2035)

    MEA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    MEA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    MEA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    MEA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    MEA Biobanking Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    GCC COUNTRIES Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    GCC COUNTRIES Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    GCC COUNTRIES Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    SOUTH AFRICA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    SOUTH AFRICA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    SOUTH AFRICA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Biobanking Market by Sample Type

    Blood Products

    Tissues

    Cells

    Nucleic Acids

    Microbiome Samples

    REST OF MEA Biobanking Market by Application Type

    Research and Development

    Clinical Trials

    Personalized Medicine

    Regenerative Medicine

    REST OF MEA Biobanking Market by End Use Type

    Academic Research Institutions

    Biotechnology Companies

    Pharmaceutical Companies

    Government Organizations

    REST OF MEA Biobanking Market by Storage Type

    Vapor Phase Storage

    Liquid Phase Storage

    Cryopreservation Storage

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027